The health edit
NUTRITION & HEALTHY AGING
Can a different diet change your biological age?
A small trial found changes in aging-related biomarkers. What that tells us—and what it leaves unanswered.
RECENTLY PUBLISHED
-
High-Fiber Diet Outperformed Metformin in a Small Trial—but Don’t Replace Medication
A small randomized trial found better short-term HbA1c and BMI results with a prescribed high-fiber intervention than metformin alone, but important design limits prevent treatment conclusions.
-
Late-Night Eating Was Linked to Fatty Liver Disease—Not Proven to Cause It
A large observational analysis links habitual late-night eating with higher relative rates of fatty liver disease and cirrhosis, but it cannot establish cause and effect.
-
Peanuts Changed a Brain Insulin Signal—but Did Not Prove Dementia Protection
A small randomized crossover trial found a regional brain blood-flow response to insulin after 16 weeks of daily peanuts, but it did not establish dementia prevention or clinical…
Recent research, explained
-
High-Fiber Diet Outperformed Metformin in a Small Trial—but Don’t Replace Medication
A small randomized trial found better short-term HbA1c and BMI results with a prescribed high-fiber intervention than metformin alone, but important design limits prevent treatment conclusions.
-
Late-Night Eating Was Linked to Fatty Liver Disease—Not Proven to Cause It
A large observational analysis links habitual late-night eating with higher relative rates of fatty liver disease and cirrhosis, but it cannot establish cause and effect.
-
Peanuts Changed a Brain Insulin Signal—but Did Not Prove Dementia Protection
A small randomized crossover trial found a regional brain blood-flow response to insulin after 16 weeks of daily peanuts, but it did not establish dementia prevention or clinical…
BEHIND THE HEADLINE
A younger biomarker profile isn’t proof of a longer life.
Research reported May 12, 2026 · Small randomized trial · 4 weeks
In a trial of 104 adults aged 65–75, several diet changes improved a biological-age estimate based on 20 biomarkers. The clearest statistical signal came from the omnivorous, higher-carbohydrate group.
The important limit: the trial did not establish longer life or fewer diseases. It excluded people with conditions including type 2 diabetes and cancer, so the findings cannot simply be applied to everyone.
From Let’s Talk Health
Full articles from 2025 onward on food, movement, and healthy aging.
-
High-Fiber Diet Outperformed Metformin in a Small Trial—but Don’t Replace Medication
A small randomized trial found better short-term HbA1c and BMI results with a prescribed high-fiber intervention than metformin alone, but important design limits prevent treatment conclusions.
-
Late-Night Eating Was Linked to Fatty Liver Disease—Not Proven to Cause It
A large observational analysis links habitual late-night eating with higher relative rates of fatty liver disease and cirrhosis, but it cannot establish cause and effect.
-
Peanuts Changed a Brain Insulin Signal—but Did Not Prove Dementia Protection
A small randomized crossover trial found a regional brain blood-flow response to insulin after 16 weeks of daily peanuts, but it did not establish dementia prevention or clinical…
-
Olive Oil Before Carbohydrates Slowed an Early Glucose Spike—in Mice
A new mouse study found that giving fat before glucose delayed gastric emptying and softened the early blood-sugar rise, but it does not establish a human treatment.
-
Potassium-Rich DASH Diet Appeared Safe With Common Blood-Pressure Medicines
A preliminary analysis of 356 adults found no dangerous potassium increase after three months of DASH-patterned groceries, but the result is not yet peer reviewed.
-
Nutrient-Dense Meals Lowered LDL—but Missed the Trial’s Main Outcomes
A 300-person randomized trial found no advantage on its primary endpoints, while LDL, blood-pressure and microbiome findings remained exploratory.
Curiosity.
With perspective.
Health headlines move quickly. Research briefs should link to their sources, identify the kind of evidence, and explain what remains unknown.
Human trials, observational studies, and animal experiments answer different questions. Promising findings deserve attention—and careful interpretation.